Correspondence 0001104659-23-008579 from Structure Therapeutics Inc. (GPCR) (CIK 0001888886) (GPCR)
Structure Therapeutics Inc. (GPCR) (CIK 0001888886)
Date: Jan. 31, 2023 · CIK: 0001888886 · Accession: 0001104659-23-008579
AI Filing Summary & Sentiment
File numbers found in text: 333-269200
Letter
January 31, 2023
Jefferies LLC
520 Madison Avenue
New York, New York 10022
SVB Securities LLC
53 State Street, 40th Floor
Boston, MA 02109
Guggenheim Securities, LLC
330 Madison Avenue
New York, New York 10017
BMO Capital Markets Corp.
151 W. 42nd Street, 31st Floor
New York, New York 10036
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Vanessa Robertson
Terence O’Brien
Jimmy McNamara
Joe McCann
Re: Structure Therapeutics Inc.
Registration Statement on Form S-1
(File No. 333-269200)
Acceleration Request
Requested Date: February 2, 2023
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), we, as representatives of the several underwriters (the “Representatives”), hereby join in the request of Structure Therapeutics Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Registrant”), that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time on February 2, 2023, or as soon thereafter as practicable, or at such other time as the Registrant or its outside counsel, Cooley LLP, request by telephone that such Registration Statement be declared effective.
Pursuant to Rule 460 under the Securities Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus, to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.
We, the undersigned Representatives, have and will, and we have been informed by the participating underwriters that they have and will, comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, in connection with the proposed offering.
[Remainder of page intentionally left blank]
Very truly yours,
Acting severally on behalf of themselves
and the several underwriters
Show Raw Text
CORRESP
1
filename1.htm
January 31, 2023
Jefferies LLC
520 Madison Avenue
New York, New York 10022
SVB Securities LLC
53 State Street, 40th Floor
Boston, MA 02109
Guggenheim Securities, LLC
330 Madison Avenue
New York, New York 10017
BMO Capital Markets Corp.
151 W. 42nd Street, 31st Floor
New York, New York 10036
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Vanessa Robertson
Terence O’Brien
Jimmy McNamara
Joe McCann
Re: Structure Therapeutics Inc.
Registration Statement on Form S-1
(File No. 333-269200)
Acceleration Request
Requested Date:
February 2, 2023
Requested Time:
4:00 P.M. Eastern
Time
Ladies and Gentlemen:
In accordance with Rule 461
of the Securities Act of 1933, as amended (the “Securities Act”), we,
as representatives of the several underwriters (the “Representatives”),
hereby join in the request of Structure Therapeutics Inc., an exempted company with limited liability
incorporated under the laws of the Cayman Islands (the “Registrant”), that the effectiveness of the above-captioned
Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time on February 2,
2023, or as soon thereafter as practicable, or at such other time as the Registrant or its outside counsel, Cooley LLP, request by telephone
that such Registration Statement be declared effective.
Pursuant
to Rule 460 under the Securities Act, please be advised that we will take reasonable steps to secure adequate distribution of the
preliminary prospectus, to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.
We, the undersigned Representatives,
have and will, and we have been informed by the participating underwriters that they have and will, comply with the requirements of Rule 15c2-8
under the Securities Exchange Act of 1934, as amended, in connection with the proposed offering.
[Remainder
of page intentionally left blank]
Very truly yours,
Acting severally on behalf of themselves
and the several underwriters
JEFFERIES LLC
SVB SECURITIES LLC
GUGGENHEIM SECURITIES, LLC
BMO CAPITAL MARKETS CORP.
JEFFERIES LLC
By:
/s/ Bryan Czyzewski
Name: Bryan Czyzewski
Title: Managing Director
SVB SECURITIES LLC
By:
/s/ Dan Dubin
Name: Dan Dubin
Title: Vice Chairman, Global Co-Head of Healthcare Investment Banking
GUGGENHEIM SECURITIES, LLC
By:
/s/ Shiv Taylor M.D.
Name: Shiv Taylor M.D.
Title: Senior Managing Director
BMO CAPITAL MARKETS CORP.
By:
/s/ Marc Ogborn
Name: Marc Ogborn
Title: Managing Director
[Signature Page to Underwriters’
Acceleration Request Letter]